Physician profile
Basil Bruno
NPI 1164509444
$2,079.10
in general payments reported to CMS, 2019-2025
13 companies · $73.36 in 2025
The $73.36 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2020: $677 · 2021: $14.53 · 2022: $34.14 · 2023: $28.58 · 2024: $1,096 · 2025: $73.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $975 · Food and Beverage: $223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $975.00 |
| Food and Beverage | $223.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verrica Pharmaceuticals INC. | $975.00 | 2024 | Ycanth |
| Allergan, INC. | $621.00 | 2020 | |
| Pfizer INC. | $122.49 | 2020-2025 | |
| Sanofi Pasteur INC. | $99.61 | 2022-2025 | |
| Gilead Sciences, INC. | $64.68 | 2019-2025 | |
| Glaxosmithkline, LLC. | $61.04 | 2019 | |
| Kaleo, INC. | $28.69 | 2019 | |
| Genentech USA, INC. | $27.64 | 2020 | |
| Qiagen, LLC | $17.47 | 2022 | |
| Mission Pharmacal Company | $16.62 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $15.86 | 2025 | |
| Neos Therapeutics, Lp | $14.61 | 2019 | |
| Cranial Technologies, INC | $14.39 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Basil Bruno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.